Purpose of Study
The Registry is intended to benefit patients, hospitals, clinicians, regulatory bodies, payers and industry by collecting data to meet the following objectives:
• To identify unique device failure modes, unanticipated adverse events or trends
• To characterize patient outcomes
• To characterize patterns of product use
• To characterize predictors of performance and effectiveness
• To identify signals of emerging performance issues
Trial Status
Enrolling
Eligibility Criteria
•Patient has or is intended to receive or be treated with an eligible Medtronic product.
• Patient within specified enrollment window
• Patient who is, or will be accessible for follow-up
• Participation is not excluded by local law
• Patient is not enrolled in a concurrent drug and/or device study that may confound registry results
Duration of Participation
- Medtronic stops the registry
- You no longer have a device followed in the registry
- You fail to keep your appointments or follow your doctor’s advice
- Your registry provider no longer participates in the registry
- If it is in your best interest
Contact Name: Rachel Hackett, RN
Contact Phone: 515-633-3845
Contact Email: rachel.hackett@mercyoneiowa.org